Finance professionals in Medical devices
Medtronic, Covidien, Boston Scientific, Smith+Nephew, Abbott and Johnson & Johnson MedTech appear across these medical device finance careers, alongside current or recent roles at Dexcom, Sonova Group, Viant Medical, Candela Medical and Nuance Medical. Their titles cover controllership, FP&A, business unit finance and the CFO seat, which suits device makers planning budgets, product line economics, manufacturing costs or an acquisition.
Professionals to explore
Brian Sill
LinkedInExperience: Chief Financial Officer · Nuance Medical
Brian Sill has been Chief Financial Officer at Nuance Medical, which provides medical products for pain management, scar and skincare and cryotherapy, since 2023. Brian was Vice President, Finance & IT at Smart Wires Inc. (2022–2023), Sr. Director, Finance - Commercial Excellence & Biologics at Stryker (2020–2022), and at Wright Medical was Sr. Director, Analytics, Automation and Finance (2019–2020) and Sr. Finance Director, US Finance (2017–2019).
Is this you? Claim your profile and get paid for calls.
Christopher Peck
LinkedInExperience: Vice President, Corporate Controller · Viant Medical
Christopher Peck has been Vice President, Corporate Controller at Viant Medical, a medical equipment manufacturing company, since 2018. Christopher was Business Unit Controller, Specialty Products at Cardinal Health (2017–2018) and Business Unit Controller, Patient Care at Medtronic (2015–2017), and at Covidien (Medtronic Minimally Invasive Therapies Group) was Business Unit Controller, Peripheral Vascular (2014–2015) and Senior Director, Vascular FP&A (2012–2014).
Is this you? Claim your profile and get paid for calls.
Danielle Welhaven, CPA, MBA
LinkedInExperience: Director of Finance, Interventional Oncology & Embolization · Boston Scientific
Danielle Welhaven, CPA, MBA has been Director of Finance, Interventional Oncology & Embolization at Boston Scientific since 2025 and was Senior Finance Manager, Peripheral Interventions - Interventional Oncology & Embolization (2024–2025), and Senior Finance Manager at Intracept by Boston Scientific (2023–2024). At Medtronic, Danielle was Financial Consultant, Neuromodulation, Pain Interventions (2022–2023) and Principal Financial Analyst, Neuromodulation, Interventional (2021–2022).
Is this you? Claim your profile and get paid for calls.
Diane Deeks
LinkedInExperience: Senior Director, North America Controller · Candela Medical
Diane Deeks, a CPA, has been Senior Director, North America Controller at Candela Medical since 2020. Diane was Senior Director, Corporate Financial Planning & Analysis at CIRCOR International, Inc. (2019–2020), and at Smith+Nephew held Finance Senior Director, LATAM Regional Controller (2015–2018), Finance Senior Director, ASD Division FP&A (2013–2015) and Finance Director, ASD Divisional Reporting (2012–2013).
Is this you? Claim your profile and get paid for calls.
Eileen Green
LinkedInExperience: Former Finance Director Operations · Laborie Medical Technology
Eileen Green was Finance Director Operations at Laborie Medical Technology (2019–2023) and Finance Director at Cardinal Health (2017–2018). Eileen was Senior Director Financial Planning & Analysis at Medtronic (2015–2017), and at Covidien (Medtronic Minimally Invasive Therapies Group) was Director of Financial Planning and Analysis (2011–2015) and Controller (2001–2011), describing hands-on work through mergers, divestitures and restructuring.
Is this you? Claim your profile and get paid for calls.
John Tanouye
LinkedInExperience: Vice President Finance · Sonova Group
John Tanouye has been Vice President Finance at Sonova Group, which specializes in hearing care, since 2021, and cites 25+ years in global medical device organizations. At Medtronic Diabetes, John was Senior Finance Director, FP&A (2018–2021) and Senior Finance Director, Operations (2015–2018), and at Boston Scientific was Director, Operations Controller (2009–2015) and Sr Mgr, Financial Planning & Analysis (2006–2009).
Is this you? Claim your profile and get paid for calls.
Pierre P.
LinkedInExperience: SVP, Group Controller Board Audit & Risk Committees FP&A M&A Treasury Tax · Smith+Nephew
At Smith+Nephew, Pierre P. has been SVP, Group Controller Board Audit & Risk Committees FP&A M&A Treasury Tax since 2025, and was SVP, CFO Global Operations, Quality and Regulatory Affairs (2023–2025), SVP, CFO Global Advanced Wound Management, and head of finance Global R&D (2021–2023), SVP, CFO Global Sports Medicine ENT Division & Latin America-Canada Region (2019–2021) and SVP, CFO International Markets (2017–2019).
Is this you? Claim your profile and get paid for calls.
Sandrine Van Doninck
LinkedInExperience: Finance Director Electrophysiology & Neurovascular · Johnson & Johnson MedTech
Based in Zug, Sandrine Van Doninck has been Finance Director Electrophysiology & Neurovascular at Johnson & Johnson MedTech since 2026, and was EMEA Franchise Controller - Electrophysiology, Neurovascular, and Aesthetics & Reconstruction there (2024–2026) and Senior Finance Manager - Vision Supply Chain (2020–2024). At Johnson & Johnson, Sandrine was Finance Manager Inventory - Janssen Business Services Janssen Supply Chain (2019–2020) and Finance Manager Global FP&A Diabetes Care (2018–2019).
Is this you? Claim your profile and get paid for calls.
Terry Kang
LinkedInExperience: Former Finance Director · Dexcom
Terry Kang was Finance Director at Dexcom (2016–2024), Senior Finance Manager at Amgen (2010–2016) and Finance Manager at Kaiser Permanente (2000–2010). Terry describes experience in budgeting, treasury, compliance and M&A across healthcare providers, pharma and medical technology companies, along with projects in R&D finance planning, so questions on funding device research fit.
Is this you? Claim your profile and get paid for calls.
Uta Holasek
LinkedInExperience: Former DVP & Controller, Medical Devices · Abbott
Uta Holasek has held a series of controller and finance titles at Abbott: DVP & Controller, Core Diagnostics since 2026, DVP & Controller, Medical Devices (2023–2026), DVP & Controller at Abbott Diabetes Care (2019–2023), Controller Global Commercial (2017–2019) and Director Finance, Global Commercial Abbott Medical Optics (2014–2017). That run suits questions on controllership across several device divisions inside one company.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Business unit and franchise finance questions fit Sandrine Van Doninck, Danielle Welhaven and John Tanouye, while controllership fits Christopher Peck, Diane Deeks, Uta Holasek and Pierre P. Brian Sill brings a Chief Financial Officer seat at Nuance Medical. Eileen Green and Terry Kang held finance director roles at Laborie Medical Technology and Dexcom until 2023 and 2024; Eileen describes work through mergers and divestitures, and Terry describes M&A and treasury work.
Questions to take into the conversation
- 01How do you set standard costs for a device line whose manufacturing volumes are still ramping?
- 02Which metrics do you track for each product franchise when deciding where to put R&D money?
- 03What finance work changes most when a device company integrates an acquired business?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.